Morgan Gareth J
Department of Congenital Cardiology,Guys and St Thomas' NHS Foundation Trust, Kings College London,London,United Kingdom.
Cardiol Young. 2016 Oct;26(7):1448-51. doi: 10.1017/S1047951116000949. Epub 2016 Jun 22.
Percutaneous closure of muscular ventricular septal defects has been well described and has not attracted the same controversy or scrutiny as perimembranous defect closure. Therefore, the development of specifically designed devices has been limited. We report the first use of the Occlutech® muscular ventricular septal defect device. Does its design add any significant benefit?
经皮封堵肌部室间隔缺损已有详细描述,且未像膜周部缺损封堵那样引发同样的争议或受到同等程度的审视。因此,专门设计的器械的研发受到限制。我们报告了Occlutech®肌部室间隔缺损封堵器的首次使用情况。其设计是否带来了任何显著益处?